Weight Loss Program Test

Weight Loss Program Test

Bloom Medspa’s weight loss program uses semaglutide or Tirzepatide. The program begins with an initial consultation with the nurse practitioner, and labs are drawn to ensure all organs are working properly. Medications and supplies are included.

The FDA approved Semaglutide in 2014 for use with Type 2 diabetics to maintain blood sugar levels. During clinical trials, Semaglutide proved it had other benefits, including improved cardiovascular risk, decreased inflammation, decreased appetite, and weight loss. In 2019, Semaglutide was FDA approved for use in patients with a BMI of 30 or greater, or a BMI of 27 and greater with at least one comorbidity, for weight management.

Semaglutide is a glucagon-like peptide-1 receptor agonist. It mimics the action of the incretin GL-1 by increasing the production of insulin. Semaglutide for weight suppresses your appetite and works in the brain’s areas that regulate appetite and food intake. In addition to using Semaglutide, an exercise program and reduced caloric intake will aid in weight loss goals and long-term management.

We also use Tirzepatide in our weight loss program. Tirzepatide, known as Mounjaro, was approved by the FDA in 2022 to treat type 2 diabetes. As with semaglutide, participants in a clinical trial on a 15 mg dose of Tirzepatide experienced a 20% weight loss.

On October 6, 2022, the FDA granted Tirzepatide a fast-track review to be used as a treatment for obesity. This designation provides Tirzepatide with a positive way to fill a serious medical need. It is used similarly to semaglutide for weight loss.

The Skintrinsiq system gives you a relaxing, spa-like facial experience that jumpstarts your skincare programs. Skintrinsiq is a great facial treatment for those who are experiencing:

The Skintrinsiq system uses pneumatic technology to provide pressure at different levels of the treatment. The Skintrinsiq device first extracts to dislodge build-up debris and impurities from the skin’s surface. Then the treatment infuses Obagi products into the skin. The Skintrinsiq also can integrate blue and red-light therapy into the treatment. The light treatments lock the product into the skin to continue working long after the facial.

FAQs

Semaglutide and Tirzepatide for weight loss is a subcutaneous injection given once a week at a dosage customized for your weight loss issues.

You may experience nausea, vomiting, diarrhea, abdominal pain, and constipation. If you have heart problems, these injections could cause a problem. Other less common side effects include elevated heart rate, allergic reactions, low blood sugar, pancreatitis, thyroid tumors, and kidney problems.

Dosages are based on your health conditions and your response to the treatments. We will start at a low dose and gradually increase your intake. These injections are used for about six months, and you will see fantastic results.

It, of course, depends on your body weight, your health, and how much product your take. In trials, it was shown that Mounjaro or Tirzepatide reduced trial participants’ weight by over 20%.

Semaglutide can provide a 15% weight loss in the first months. Then, as you increase your dosage, you can lose more weight.

Have more questions?

Contact: [email protected] for more information

Keep in touch!

Call Now Button